Minase Research Institute, Ono Pharmaceutical Co., Ltd, Shimamoto, Mishima, Osaka 618-8585, Japan.
Bioorg Med Chem. 2010 Jan 1;18(1):80-90. doi: 10.1016/j.bmc.2009.11.023. Epub 2009 Nov 12.
A series of 3-(2-aminocarbonyl-4-phenoxymethylphenyl)propanoic acid analogs were synthesized and evaluated for their EP3 antagonist activity in the presence of additive serum albumin. Several compounds were biologically evaluated for their in vivo efficacy with respect to the PGE(2)-induced uterine contraction in pregnant rats as well as their pharmacokinetics. The discovery process of these potent and selective EP3 antagonists and their structure activity relationship are also presented.
一系列 3-(2-氨基甲酰基-4-苯氧甲基苯基)丙酸类似物被合成并在添加血清白蛋白的情况下评估其 EP3 拮抗剂活性。几种化合物在体内的功效也针对孕鼠中 PGE(2)诱导的子宫收缩以及它们的药代动力学进行了生物学评估。还介绍了这些有效且选择性的 EP3 拮抗剂的发现过程及其结构活性关系。